TLSA: Tiziana Life Sciences Ltd Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 161.45
Enterprise Value ($M) 157.72
Book Value ($M) 3.94
Book Value / Share 0.04
Price / Book 41.02
NCAV ($M) 0.16
NCAV / Share 0.00
Price / NCAV 1,009.04

Profitability (mra)
Return on Invested Capital (ROIC) -2.93
Return on Assets (ROA) -1.08
Return on Equity (ROE) -6.40

Liquidity (mrq)
Quick Ratio 1.02
Current Ratio 1.02

Balance Sheet (mrq) ($M)
Current Assets 7.51
Assets 11.28
Liabilities 7.35
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -15.79
Net Income -11.86

Cash Flow Statement (mra) ($M)
Cash From Operations -1.53
Cash from Investing -0.02
Cash from Financing 4.45

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-12 124,445 433,977 28.68
2025-05-09 114,972 679,969 16.91
2025-05-08 23,312 189,010 12.33
2025-05-07 172,511 1,008,782 17.10

(click for more detail)

Similar Companies
THAR – Tharimmune, Inc. THTX – Theratechnologies Inc.
TIL – Instil Bio, Inc. TNFA – TNF Pharmaceuticals, Inc.
TNXP – Tonix Pharmaceuticals Holding Corp.


Financial data and stock pages provided by
Fintel.io